Thursday 1/27 Insider Buying Report: PLL, MACK

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.

On Tuesday, Piedmont Lithium's , Jeffrey T. Armstrong, made a $109,438 buy of PLL, purchasing 2,500 shares at a cost of $43.78 a piece. So far Armstrong is in the green, up about 6.2% on their purchase based on today's trading high of $46.49. Piedmont Lithium is trading off about 0.3% on the day Thursday. Before this latest buy, Armstrong bought PLL at 3 other times during the past twelve months, for a total cost of $426,769 at an average of $56.90 per share.

And at Merrimack Pharmaceuticals, there was insider buying on Monday, by Director Ulrik B. Nielsen who purchased 14,287 shares for a cost of $4.24 each, for a total investment of $60,630. This purchase marks the first one filed by Nielsen in the past twelve months. Merrimack Pharmaceuticals is trading off about 2.3% on the day Thursday. Nielsen was up about 22.1% on the buy at the high point of today's trading session, with MACK trading as high as $5.18 in trading on Thursday.

VIDEO: Thursday 1/27 Insider Buying Report: PLL, MACK

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.